Clinical Trials Browser

Phase NA × irinotecan sucrosofate × 30 days × Clear all

NCT07474103 2026-03-16

SCRT-NALIRIXELOX+Sintilimab as TNT for High-Risk LARC

Phase NA Recruiting

Gastrointestinal

Rectal Neoplasms